Natarajan Sethuraman, Chief Scientific Officer: Entrada Therapeutics TRDA Sell · Filed 24/09/10

Trade details

Type: Insider sale
Amount: $39,867.78
Shares · price: 2,642 sh · $15.09 a share
Held after: 183,816 sh
Stock: Entrada Therapeutics TRDA
Person: Natarajan SethuramanChief Scientific Officer
Trade date: 24/09/09
Filed: 24/09/10
Days to filing: 1 days

Sold 1.4% of holdings

Share of holding sold: 1.4%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 24/08/10~24/10/09

Natarajan Sethuraman's recent trades

Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$398.7K
25,907 sh
$398.7K
Filed 05/04
Traded 05/04
Natarajan SethuramanPresident, Research & Develop
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$375.7K
25,907 sh
$375.7K
Filed 05/04
Traded 05/04
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$235.8K
11,703 sh
$235.8K
Filed 24/12/03
Traded 24/12/03
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$82.8K
4,088 sh
$82.8K
Filed 24/12/03
Traded 24/12/02
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$2,000
100 sh
$2,000
Filed 24/12/03
Traded 24/11/29

Natarajan Sethuraman, Chief Officer — sold $39.9K of Entrada Therapeutics TRDA · 1.4% of holdings · 10b5-1 plan | Whalegun